AG

Archana Ganesh Yamgar

Active Director Designated Partner DIN 11377691
DIN 11377691 First appointment Nov 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Archana Ganesh Yamgar

Data last updated:

Archana Ganesh Yamgar is a Designated Partner at Shri Siddhivinayak Clinical And Research Center Llp (since 2024).

DIN 11377691
Primary Designation Designated Partner
First Appointment 25 Nov 2024

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner25 Nov 2024Active

Board colleagues of Archana Ganesh Yamgar

Directorship timeline

Open interactive timeline →
Shri Siddhivinayak Clinical And Research Center Llp
Premium access

Shareholding and investment profile for Archana Ganesh Yamgar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Archana Ganesh Yamgar

Archana Ganesh Yamgar currently holds 1 directorship: Shri Siddhivinayak Clinical And Research Center Llp (Designated Partner, since 25 Nov 2024).

Archana Ganesh Yamgar was first appointed on 25 Nov 2024 as Designated Partner at Shri Siddhivinayak Clinical And Research Center Llp.

The current boards of Archana Ganesh Yamgar's companies include Ganesh Tatoba Yamgar (Shri Siddhivinayak Clinical And Research Center Llp), Hemant Tukaram Mote (Shri Siddhivinayak Clinical And Research Center Llp), Vidya Sachin Mote (Shri Siddhivinayak Clinical And Research Center Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available